SEARCH RESULTS FOR: "Tag: ALXN"
REFINE YOUR SEARCH:
RECENT
Last Month(1)
ARTICLES/BLOGS
2019(2)
2018(4)
2017(9)
2016(9)
2015(5)
CATEGORIES
Analyst Downgrades(2)
Analyst Update(3)
Analyst Upgrades(1)
Best and Worst Stocks(6)
Buzz Stocks(2)
By the Numbers(5)
Editor's Pick(4)
Expectational Analysis(2)
General(2)
Indexes and ETFs(2)
Intraday Option Activity(1)
Midday Market Check(1)
Opening View(3)
Quantitative Analysis(4)
Stocks On the Move(3)
Best Stocks to Buy Before July
https://www.schaeffersresearch.com/content/analysis/2019/06/26/best-stocks-to-buy-before-july
6/26/2019 11:29 AM
June has been a banner month for the U.S. stock market, with the S&P 500 Index (SPX) on pace for its best month since January, and assailing fresh all-time highs. What's more, several stocks could ex...
2 Reasons to Like This Pharma Stock Right Now
https://www.schaeffersresearch.com/content/analysis/2019/05/29/2-reasons-to-like-this-pharma-stock-right-now
5/29/2019 12:34 PM
Like most of the stock market, the shares of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) have struggled in May, down nearly 10% so far. However, now could be an opportune time to roll the dice on a ...
2 Surging Drug Stocks Seeing Heavy Options Trading
https://www.schaeffersresearch.com/content/news/2018/09/26/2-surging-drug-stocks-seeing-heavy-options-trading
9/26/2018 3:18 PM
The U.S. stock market is mixed at midday, as traders digest the latest policy news from the Fed. Among individual names in focus are Soliris maker Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN), Lyme D...
Best and Worst Stocks to Buy Before July
https://www.schaeffersresearch.com/content/analysis/2018/06/25/best-and-worst-stocks-to-buy-before-july
6/25/2018 2:53 PM
We're almost to the halfway point of 2018, with July kicking off next week. As such, we decided to take a look at the best and worst stocks to own during the month, historically. Among the outperforme...
2 Biotech Stocks That Could Blast Off This Summer
https://www.schaeffersresearch.com/content/analysis/2018/06/04/2-biotech-stocks-that-could-blast-off-this-summer
6/4/2018 1:25 PM
Drug stocks are making waves today, as traders digest cancer treatment updates from the American Society of Clinical Oncology (ASCO) conference. The shares of Celgene Corporation (NASDAQ:CELG) partn...
Welcome to Schaeffer's Investment Research! We are a privately held provider of stock and options trading recommendations, options education, and market commentary, headquartered in Cincinnati, Ohio. Founded in 1981 by industry pioneer Bernie Schaeffer, we've since become a trusted source of research and analysis for individual investors and major financial media outlets alike.
More About
Schaeffer's
Contact
Us
Partner Center